Upvote
Downvote
Executive Director, Global Market Access
Share Job
- Suggest Revision
$321,000 a year
Full-time
- Avidity is revolutionizing the field of RNA with its proprietary AOCs, which are designed to combine the specificity of monoclonal antibodies with the precision of oligonucleotide therapies to address targets and diseases previously unreachable with existing RNA therapies.
- Avidity Biosciences, Inc.'s mission is to profoundly improve people's lives by delivering a new class of RNA therapeutics - Antibody Oligonucleotide Conjugates (AOCs™).
- Utilizing its proprietary AOC platform, Avidity demonstrated the first-ever successful targeted delivery of RNA into muscle and is leading the field with clinical development programs for three rare muscle diseases: myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).
- Partner with commercial and medical affairs colleagues to develop global market access strategies and plans, in assigned regions, for Avidity’s rare disease pipeline products through various stages of development.
- Create global value dossiers, cost-effectiveness and budget impact models and market entry plans for in-country Health Technology Assessment (HTA) and pricing & reimbursement submissions, within product development timelines.
Active Job
Updated 2 months agoSimilar Job
Relevance
Active